Comparison of Clinical Effectiveness of Folfirinox versus Gemcitabine on Quality of Life in Patients with Pancreatic Cancer Stage IV. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 11, n. 03, 2017. DOI: 10.22377/ajp.v11i03.1468. Disponível em: https://www.asiapharmaceutics.info/index.php/ajp/article/view/1468. Acesso em: 14 apr. 2026.